Financial Analysis

NOTE 10 COMMITMENTS AND CONTINGENCIES From time to time, the Company is subject to various legal proceedings and claims, either asserted or unasserted, that arise in the ordinary course of business. Although the outcome of the various legal proceedings and claims cannot be predicted with certainty, management does not believe that any of these proceedings or other claims will have a material effect on the Companys business, financial condition, results of operations or cash flows. Termination of acquisition agreement of SB Security Holdings, LLC On March 30, 2025, the Company entered into a Share Exchange Agreement (the SEA) to acquire SB Security Holdings, LLC, a Delaware limited liability company (SBSH), which is an internet connected video doorbell service company. Pursuant to the SEA, the Company agreed to purchase all of the issued and outstanding membership interests in SBSH (the Acquisition) in exchange for a number of newly issued shares of the Companys common stock equal to ninety percent (90%) of the total number of issued and outstanding shares of the Companys common stock, on a fully-diluted basis, as of the closing of the Acquisition. The closing of the Acquisition is subject to customary closing conditions, including mutual agreement as to the legal transaction structure, approval by the Companys stockholders, and Nasdaq approval. On June 13, 2025, the Company terminated the SEA. NASDAQ Deficiencies On September 19, 2025, the Company received a delinquency notif …

CommitmentsAndContingenciesDisclosureTextBlock · excerpt; the full note is in the filing

NOTE 7 NOTES PAYABLE Upper Clapton Convertible Promissory Note On September 12, 2022, the Company issued a $1,308,270 promissory note used to acquire four market-approved anti-cancer drugs. See Note 4 Intangible Assets for further discussion. The promissory note bore interest at 6% and had a maturity date of June 30, 2023. Pursuant to the agreement, the interest stopped accruing at June 30, 2023. As of December 31, 2023, the Company made interest payments of $78,496 to fully satisfy the interest obligation under the promissory note. The note was converted into the Companys common shares and fully settled as part of the merger that closed on June 21, 2024. The outstanding principal balance of the note was $0 at December 31, 2025 and 2024. Redwoods PIPE Investor Convertible Promissory Note On March 4, 2024, in connection with the Merger, Public ANEW entered into a convertible promissory note that bore an interest of 10% and Securities Purchase Agreement (SPA) with certain accredited investors (the Redwoods PIPE Investors) for an aggregate purchase price of up to $2,000,000 (the Redwoods PIPE Financing), which included 750,000 bonus shares of common stock. Upon the closing of the Redwoods PIPE Financing (funded and closed in connection with the closing of the Merger on June 21, 2024), which totaled $1,950,000, of which $1,768,661 was used by the Company to settle transaction costs. The Company received approximately $181,339 in net cash proceeds. The note and related interest we …

DebtDisclosureTextBlock · excerpt; the full note is in the filing

NOTE 11 INCOME TAXES The Company accounts for income taxes under ASC 740 - Income Taxes (ASC 740), which provides for an asset and liability approach of accounting for income taxes. Under this approach, deferred tax assets and liabilities are recognized based on anticipated future tax consequences, using currently enacted tax laws, attributed to temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts calculated for income tax purposes. Significant components of the Companys deferred tax assets as of December 31, 2025 and 2024 are summarized below. December 31, 2025 December 31, 2024 Deferred Tax Assets (Liabilities): Net operating losses carried forward $ 4,312,919 $ 2,389,968 Interest expense 485,932 74,887 Share-based compensation 328,695 556,410 Change in fair value of warrant liability (5,988 ) (412 ) Total deferred tax assets (liabilities): 5,120,829 3,020,853 Less valuation allowance (5,120,829 ) (3,020,853 ) Net deferred tax asset (liability) $ - $ - The Company recognizes deferred tax assets to the extent that it believes that these assets are more likely than not to be realized. In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. The Company assessed the need for a valuation allowance against …

IncomeTaxDisclosureTextBlock · excerpt; the full note is in the filing

Recent Accounting Pronouncements In June 2016, the FASB issued ASU 2016-13, Financial Instruments Credit Losses, which requires entities to estimate all expected credit losses for financial assets measured at amortized cost basis, including trade receivables, held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. The Company adopted this guidance on January 1, 2023. The adoption of this accounting standard did not have an impact on the Companys consolidated financial statements as the Company is in a pre-revenue state and does not generate revenue and has no receivables from third party. In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures , which requires incremental disclosure of segment information on an interim and annual basis. This ASU is effective for public entities for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Retrospective application to all prior periods presented in the financial statements is required for public entities. The Company adopted ASU 2023-07 as of January 1, 2024, which resulted in additional disclosures of significant segment expenses and other segment items as well as incremental qualitative disclosures. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures , which enhances the …

NewAccountingPronouncementsPolicyPolicyTextBlock · excerpt; the full note is in the filing

NOTE 8 RELATED PARTIES On October 24, 2024, Dr. Joseph Sinkule and the Company entered into an Employment Agreement for a term of three years in connection with his appointment as the Companys Chief Executive Officer. Pursuant to the Employment Agreement, Dr. Sinkule will receive an annual base salary of $360,000 and an initial equity award of 1,000,000 options pursuant to the Companys 2023 Incentive Plan vesting immediately. The options are valid for a period of three (3) years and have an exercise price equal to the closing price of the Companys common stock on October 24, 2024. In addition, Dr. Sinkule will be eligible to participate in the Companys annual bonus program for executives. On August 15, 2024, Mr. Peter Moriarty and the Company entered into an Employment Agreement for a term of three years in connection with his appointment as the Companys Chief Operating Officer. Pursuant to the Employment Agreement, Mr. Moriarty will receive an annual base salary of $300,000 and an initial equity award of shares of the Companys common stock of 100,000 shares and an additional equity award of 400,000 shares of the Companys common stock, with 200,000 of such shares vesting on the first anniversary of the agreement and 200,000 of such shares vesting on the second anniversary of the agreement. In addition, Mr. Moriarty will be eligible to participate in the Companys annual bonus program for executives. On August 15, 2024, Mr. Jeffrey LeBlanc and the Company entered into an Employ …

RelatedPartyTransactionsDisclosureTextBlock · excerpt; the full note is in the filing

NOTE 12 SEGMENT INFORMATION Operating segments are defined as components of an entity for which separate financial information is available and that is regularly reviewed by the Chief Operating Decision Maker (CODM) in deciding how to allocate resources to an individual segment and in assessing performance. The Company operates as a single reporting segment, focused on developing essential medicines for the treatment of chronic diseases cancer, cardiovascular, and neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and two proprietary, patented technologies involving the melanocortin receptor-binding molecules and a gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. The Companys measure of segment profit or loss is net loss. The CODM is the chief executive officer (CEO). The CODM manages and allocates resources to the operations of the Company on a total company basis. Managing and allocating resources on a consolidated basis enables the CEO to assess the overall level of resources available and how to best deploy these resources across functions and research and development projects that are in line with the Companys long-term company-wide strategic goals. Consistent with this decision-making process, the CEO uses consolidated f …

SegmentReportingDisclosureTextBlock · excerpt; the full note is in the filing

NOTE 2 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Going Concern The accompanying audited consolidated financial statements have been prepared as if the Company will continue as a going concern. The Company has incurred significant operating losses and negative cash flows from operations since inception. As of December 31, 2025, the Company had cash and cash equivalents of approximately $7.2 million and an accumulated deficit of approximately $21.1 million. The Company has incurred recurring losses, has experienced recurring negative operating cash flows, and requires significant cash resources to execute its business plans. The Company is dependent on obtaining additional working capital funding from the sale of equity and/or debt securities in order to continue to execute its development plans and continue operations. Without additional funding, there is substantial doubt about the Companys ability to continue as a going concern for twelve months from the date of these financial statements. Basis of Presentation and Principles of Consolidation The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (US GAAP) and pursuant to the rules and regulations of the Securities Exchange Commission (SEC). Emerging Growth Company The Company is an emerging growth company, as defined in Section 2(a) of the Securities Act of 1933, as amended (the Securities Act), as modified by the Jum …

SignificantAccountingPoliciesTextBlock · excerpt; the full note is in the filing

NOTE 9 STOCKHOLDERS EQUITY Business Combination On June 21, 2024, the Business Combination, among other transactions contemplated by the Business Combination Agreement, was completed. The transaction was accounted for as a reverse recapitalization in accordance with GAAP. Under this method of accounting, Redwoods was treated as the acquired company for financial reporting purposes. Accordingly, for accounting purposes, the financial statements of the Combined Company represent a continuation of the financial statements of the Company with the Transactions treated as the equivalent of the Company issuing shares for the net assets of Redwoods, accompanied by recapitalization. Under this method of accounting, Redwoods was treated as the acquired company for financial reporting purposes. Accordingly, for accounting purposes, the Merger was treated as the equivalent of the Company issuing shares for the net assets of Redwoods, accompanied by a recapitalization. The net assets of Redwoods were stated at historical cost with no goodwill or other intangible assets recorded. See NOTE 1 Organization and Business Description for detail. Equity Incentive Plan In connection with the Business Combination, the Companys Board adopted, and the Companys stockholders approved, the Equity Incentive Plan (Equity Incentive Plan). Although the Company does not have a formal policy with respect to the grant of equity incentive awards to the Companys executive officers, the Company believes that equi …

StockholdersEquityNoteDisclosureTextBlock · excerpt; the full note is in the filing

NOTE 13 SUBSEQUENT EVENTS The Company has evaluated subsequent events pursuant to the requirements of ASC Topic 855, from the balance sheet date through the date the financial statements were issued, and has determined that the following subsequent event exists: Merger On March 4, 2026, the Company entered into an Agreement and Plan of Merger (the Merger Agreement) with Greenland Mines Corp., a Delaware corporation (Greenland Mines). Pursuant to the terms of the Merger Agreement, at the closing, Greenland Mines will merge into GM Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of the Company (Merger Sub), with Greenland Mines being the surviving entity. Pursuant to the Merger Agreement, as consideration for the Merger, the stockholders of Greenland Mines will receive a total of 47,000 newly issued shares of the Companys Series C Preferred Stock. In addition, the stockholders of Greenland Mines have the right to designate one individual to join the Companys Board of Directors. The Merger Agreement also contains customary representations and warranties of the parties. On March 4, 2026 (the Closing Date), at the closing of the Merger Agreement, Merger Sub merged into Greenland Mines, with Greenland Mines being the surviving entity (the Subsidiary Merger). As a result of the Subsidiary Merger, Greenland Mines became a wholly-owned subsidiary of the Company (the Merger Transaction). The Merger Transaction did not result in a change of control of the Company or …

SubsequentEventsTextBlock · excerpt; the full note is in the filing